Auto saved by Logseq

assets/Rethinking_Chagas_Report_21JUN2021-1_1704450708173_0.edn

@@ -251,5 +251,39 @@
                                    :height 1584}),
                           :page 3},
                :content {:text "Seek avenues to advocate for policies that will enhance scalability of these efforts and improve care for populations with or at high risk of Chagas disease"},
+               :properties {:color "yellow"}}
+              {:id #uuid "6597ebb7-7e99-46f7-b139-98af95731702",
+               :page 4,
+               :position {:bounding {:x1 206.35447311401367,
+                                     :y1 1307.7674255371094,
+                                     :x2 932.4571342468262,
+                                     :y2 1334.7884216308594,
+                                     :width 1224,
+                                     :height 1584},
+                          :rects ({:x1 206.35447311401367,
+                                   :y1 1307.7674255371094,
+                                   :x2 932.4571342468262,
+                                   :y2 1334.7884216308594,
+                                   :width 1224,
+                                   :height 1584}),
+                          :page 4},
+               :content {:text "Re-engage Ortho in discussions to make its T. cruzi ELISA commercially available."},
+               :properties {:color "yellow"}}
+              {:id #uuid "6597ebbe-e6fb-4b11-8901-8a4dc8950543",
+               :page 4,
+               :position {:bounding {:x1 206.35447311401367,
+                                     :y1 1348.6298522949219,
+                                     :x2 939.6749076843262,
+                                     :y2 1375.6508483886719,
+                                     :width 1224,
+                                     :height 1584},
+                          :rects ({:x1 206.35447311401367,
+                                   :y1 1348.6298522949219,
+                                   :x2 939.6749076843262,
+                                   :y2 1375.6508483886719,
+                                   :width 1224,
+                                   :height 1584}),
+                          :page 4},
+               :content {:text "Explore opportunities to reduce the entry barrier for new tests, including rapid tests"},
                :properties {:color "yellow"}}],
- :extra {:page 4}}
+ :extra {:page 5}}

pages/hls__Rethinking_Chagas_Report_21JUN2021-1_1704450708173_0.md

@@ -51,3 +51,13 @@ file-path:: ../assets/Rethinking_Chagas_Report_21JUN2021-1_1704450708173_0.pdf
   hl-page:: 3
   hl-color:: yellow
   id:: 6597eb2f-6e68-4b48-b4b2-52d1d6ff2fa0
+- Re-engage Ortho in discussions to make its T. cruzi ELISA commercially available.
+  ls-type:: annotation
+  hl-page:: 4
+  hl-color:: yellow
+  id:: 6597ebb7-7e99-46f7-b139-98af95731702
+- Explore opportunities to reduce the entry barrier for new tests, including rapid tests
+  ls-type:: annotation
+  hl-page:: 4
+  hl-color:: yellow
+  id:: 6597ebbe-e6fb-4b11-8901-8a4dc8950543